Prostate cancer growth and development rely on androgens (testosterone and dihydrotestosterone) which leads to differentiation and proliferation of epithelial prostate cells via androgen receptor signaling, thus making way for androgen deprivation therapy as one of the most popular therapeutic approaches in prostate cancer treatment. This evidence concerns the gene AR and prostate carcinoma.